secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atara Biotherapeutics, Inc. (ATRA)
CIK:        0001604464
Form:       8-K
Filed at:   2021-08-10T23:59:59+00:00
Accession:  0001193125-21-241776
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Atara Biotherapeutics appoints Ameet Mallik to Board of Directors
-----------------------------------------------------------------

- Ameet Mallik appointed to fill vacant Board seat effective August 9, 2021.
- Initial term expires at 2024 annual meeting; no standing committee assignments.
- Mr. Mallik determined independent under SEC and Nasdaq listing standards.
- Receives annual retainer of $45,000 (pro-rated) and option for 55,000 shares vesting over 3 years.
- Standard indemnification agreement entered into with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604464/000119312521241776/0001193125-21-241776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604464/000119312521241776/d213682d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-241776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer